vs

Side-by-side financial comparison of Offerpad Solutions Inc. (OPAD) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Vertex, Inc. is the larger business by last-quarter revenue ($196.6M vs $114.1M, roughly 1.7× Offerpad Solutions Inc.). On growth, Vertex, Inc. posted the faster year-over-year revenue change (11.1% vs -34.5%). Offerpad Solutions Inc. produced more free cash flow last quarter ($65.7M vs $7.7M). Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (10.5% CAGR vs -36.8%).

Offerpad Solutions Inc is a prominent U.S. proptech firm focused on simplifying residential real estate transactions. Operating under the iBuyer model, it purchases homes directly from sellers, conducts required renovations, and resells properties to buyers. It also provides supporting services including mortgage assistance, title services, and flexible moving options for clients across dozens of U.S. states.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

OPAD vs VERX — Head-to-Head

Bigger by revenue
VERX
VERX
1.7× larger
VERX
$196.6M
$114.1M
OPAD
Growing faster (revenue YoY)
VERX
VERX
+45.6% gap
VERX
11.1%
-34.5%
OPAD
More free cash flow
OPAD
OPAD
$58.1M more FCF
OPAD
$65.7M
$7.7M
VERX
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
10.5%
-36.8%
OPAD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPAD
OPAD
VERX
VERX
Revenue
$114.1M
$196.6M
Net Profit
$-2.5M
Gross Margin
7.0%
63.5%
Operating Margin
31.1%
Net Margin
-1.3%
Revenue YoY
-34.5%
11.1%
Net Profit YoY
49.1%
-122.6%
EPS (diluted)
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPAD
OPAD
VERX
VERX
Q1 26
$196.6M
Q4 25
$114.1M
$194.7M
Q3 25
$132.7M
$192.1M
Q2 25
$160.3M
$184.6M
Q1 25
$160.7M
$177.1M
Q4 24
$174.3M
$178.5M
Q3 24
$208.1M
$170.4M
Q2 24
$251.1M
$161.1M
Net Profit
OPAD
OPAD
VERX
VERX
Q1 26
$-2.5M
Q4 25
$-7.0M
Q3 25
$-11.6M
$4.0M
Q2 25
$-10.9M
$-961.0K
Q1 25
$-15.1M
$11.1M
Q4 24
$-17.3M
$-67.8M
Q3 24
$-13.5M
$7.2M
Q2 24
$-13.8M
$5.2M
Gross Margin
OPAD
OPAD
VERX
VERX
Q1 26
63.5%
Q4 25
7.0%
64.8%
Q3 25
7.0%
63.1%
Q2 25
8.9%
65.7%
Q1 25
6.5%
63.8%
Q4 24
6.1%
65.6%
Q3 24
8.2%
64.8%
Q2 24
8.7%
63.7%
Operating Margin
OPAD
OPAD
VERX
VERX
Q1 26
31.1%
Q4 25
-1.3%
Q3 25
-5.1%
2.2%
Q2 25
-4.9%
-2.1%
Q1 25
-7.2%
2.5%
Q4 24
-7.8%
-7.3%
Q3 24
-4.3%
2.9%
Q2 24
-3.9%
4.7%
Net Margin
OPAD
OPAD
VERX
VERX
Q1 26
-1.3%
Q4 25
-3.6%
Q3 25
-8.7%
2.1%
Q2 25
-6.8%
-0.5%
Q1 25
-9.4%
6.3%
Q4 24
-9.9%
-38.0%
Q3 24
-6.5%
4.2%
Q2 24
-5.5%
3.2%
EPS (diluted)
OPAD
OPAD
VERX
VERX
Q1 26
$-0.02
Q4 25
Q3 25
$-0.37
Q2 25
$-0.39
Q1 25
$-0.55
Q4 24
$-0.64
Q3 24
$-0.49
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPAD
OPAD
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$26.5M
$252.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$38.2M
$246.5M
Total Assets
$154.8M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPAD
OPAD
VERX
VERX
Q1 26
$252.5M
Q4 25
$26.5M
$314.0M
Q3 25
$31.0M
$313.5M
Q2 25
$22.6M
$284.4M
Q1 25
$30.8M
$270.4M
Q4 24
$43.0M
$296.1M
Q3 24
$48.5M
$279.0M
Q2 24
$56.9M
$325.5M
Total Debt
OPAD
OPAD
VERX
VERX
Q1 26
Q4 25
$337.5M
Q3 25
$336.9M
Q2 25
$336.3M
Q1 25
$335.8M
Q4 24
$335.2M
Q3 24
$334.7M
Q2 24
$334.1M
Stockholders' Equity
OPAD
OPAD
VERX
VERX
Q1 26
$246.5M
Q4 25
$38.2M
$258.9M
Q3 25
$39.9M
$264.5M
Q2 25
$24.5M
$248.0M
Q1 25
$34.2M
$200.5M
Q4 24
$47.7M
$179.4M
Q3 24
$64.7M
$259.0M
Q2 24
$77.6M
$233.1M
Total Assets
OPAD
OPAD
VERX
VERX
Q1 26
$1.2B
Q4 25
$154.8M
$1.3B
Q3 25
$223.5M
$1.2B
Q2 25
$268.0M
$1.2B
Q1 25
$274.5M
$1.2B
Q4 24
$313.1M
$1.2B
Q3 24
$338.5M
$1.2B
Q2 24
$406.6M
$1.0B
Debt / Equity
OPAD
OPAD
VERX
VERX
Q1 26
Q4 25
1.30×
Q3 25
1.27×
Q2 25
1.36×
Q1 25
1.67×
Q4 24
1.87×
Q3 24
1.29×
Q2 24
1.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPAD
OPAD
VERX
VERX
Operating Cash FlowLast quarter
$66.8M
$38.0M
Free Cash FlowOCF − Capex
$65.7M
$7.7M
FCF MarginFCF / Revenue
57.6%
3.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPAD
OPAD
VERX
VERX
Q1 26
$38.0M
Q4 25
$66.8M
$42.3M
Q3 25
$40.0M
$62.5M
Q2 25
$-13.5M
$46.0M
Q1 25
$-10.2M
$14.8M
Q4 24
$20.8M
$41.1M
Q3 24
$39.6M
$41.4M
Q2 24
$-54.4M
$57.7M
Free Cash Flow
OPAD
OPAD
VERX
VERX
Q1 26
$7.7M
Q4 25
$65.7M
Q3 25
Q2 25
$-13.6M
Q1 25
$-11.2M
Q4 24
$15.4M
Q3 24
$38.7M
$-24.3M
Q2 24
$-54.4M
FCF Margin
OPAD
OPAD
VERX
VERX
Q1 26
3.9%
Q4 25
57.6%
Q3 25
Q2 25
-8.5%
Q1 25
-7.0%
Q4 24
8.9%
Q3 24
18.6%
-14.2%
Q2 24
-21.7%
Capex Intensity
OPAD
OPAD
VERX
VERX
Q1 26
Q4 25
0.9%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.6%
Q4 24
3.1%
Q3 24
0.4%
38.5%
Q2 24
0.0%
Cash Conversion
OPAD
OPAD
VERX
VERX
Q1 26
Q4 25
Q3 25
15.44×
Q2 25
Q1 25
1.33×
Q4 24
Q3 24
5.73×
Q2 24
11.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPAD
OPAD

Segment breakdown not available.

VERX
VERX

Software subscriptions$167.1M85%
Services$29.5M15%

Related Comparisons